Digital Health Hub

DECEMBER 6, 2022

Is your 2023 calendar filling up? Here are some digital health events scheduled for 2023. Click on the links to visit the event homepage and also to access the schedule. Last Update : Dec 6,2022. If you are a digital health event organizer, and want to feature your event here, please contact here.

Digital Health 40

Digital Health Healthcare IT BioTech Healthcare Innovation 40

Digital Health Hub

DECEMBER 6, 2022

Is your 2023 calendar filling up? Here are some digital health events scheduled for 2023. Click on the links to visit the event homepage and also to access the schedule.

Digital Health 40

Digital Health Healthcare IT BioTech Healthcare Innovation 40

Health Populi

MAY 4, 2023

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. Reading between the lines of the 2023 IQVIA report tells us as much about public health risks as it does medicines use. is always a detailed, deep, and insightful dive into the state of prescription drugs.

Public Health 156

Public Health Mental health Life Science Telehealth 156

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 64

Life Science Digital Health EHR BioTech 64

Healthcare IT Today

JANUARY 9, 2023

As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. That level of analytics sophistication is finally being realized and will go mainstream in 2023, reshaping the way that healthcare organizations leverage data and improve patient outcomes. Dr. Ofer Sharon, CEO at OncoHost.

Health IT 87

Health IT Pharmaceuticals Drug Development Life Science 87

Digital Health Global

APRIL 17, 2024

Debut Biotech : A leading cell-free biomanufacturing company that launched its own skin care product line in 2023 and raised a $20 million Series B led by L’Oreal. Pathology Watch : An end-to-end dermatopathology software platform, including AI interpretation; acquired by Sonic Healthcare in January 2024 for $150 million.

Life Science 88

Life Science BioTech Healthcare Innovation Digital Health 88

Digital Health Global

OCTOBER 11, 2023

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.

Life Science 167

Life Science Pharmaceuticals BioTech Leadership 167

Digital Health Global

AUGUST 15, 2023

–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.

Life Science 88

Life Science Leadership BioTech Digital Health 88

Digital Health Global

MARCH 1, 2023

The current B Capital global healthcare portfolio includes over 20 companies in the US, Asia and Europe, spanning early venture to late growth venture, across healthtech, digital health, biotech and medtech. The team also led the latest financing in CapitalRX, a transformative tech platform for pharmacy benefits management. billion.

Healthcare Innovation 88

Healthcare Innovation BioTech Digital Health 88

Digital Health Global

APRIL 15, 2024

Today’s announcement comes following the October 2023 acquisition of Healthware Group , an agency and innovation consultancy headquartered in Salerno, Italy. The new affiliate will operate from multiple offices across Italy, Finland, the United Kingdom and the United States, focused on innovation, transformation and client delight.

Life Science 88

Life Science Pharmaceuticals BioTech Digital Health 88

Healthcare IT Today

OCTOBER 11, 2023

Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. RedHealthy Communications : PR and marketing for biotech, life sciences, and digital health. This article will be a roundup of interesting stories, product announcements, partnerships, research studies, company launches, and more from the annual conference.

Life Science 71

Life Science EHR BioTech RCM 71

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Accessed November 2023. Accessed November 2023. Nat Med (2023).

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Healthcare IT Today

NOVEMBER 7, 2023

“This investment provides us with the resources to further advance our platform and expand our reach to additional pharma, CRO, and biotech companies in Europe and the U.S., Originally announced October 24th, 2023 Raviv Pryluk, Co-Founder and CEO at PhaseV. bringing new needed treatments to patients.”

Drug Development 64

Drug Development BioTech Pharmaceuticals Health IT 64

Healthcare IT Today

SEPTEMBER 24, 2023

Collaborations between AI vendors and biotech/pharma companies over the last five years are worth more than $45 billion , according to a recent report from Accenture. Over the same time period, investment in AI-powered drug discovery start-ups grew by $840 million.

Medical Billing 107

Medical Billing EHR Medicare BioTech 107

Healthcare IT Today

MAY 7, 2023

Global venture capital funding was just $21 billion in April 2023 , a 56% drop from April 2022, according to Crunchbase. The silver lining: Healthcare is the leading sector, though most funds are going to biotech. Awards The 2023 MedTech Breakthrough Awards have been announced, with more than 140 overall winners in 20 categories.

RCM 76

RCM EHR Mental health BioTech 76

Digital Health Global

MAY 8, 2023

The transaction is expected to close in the second half of 2023, subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions. For the full fourth quarter 2023, Baxter estimates the transaction to result in dilution of approximately $0.10 Advent International Inc.

Pharmaceuticals 88

Pharmaceuticals Life Science BioTech Leadership 88

Healthcare IT Today

SEPTEMBER 18, 2023

Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics. Originally announced August 28th, 2023 The company was recently founded in 2022 and has achieved tangible success for both itself and its clients.

BioTech 84

BioTech Digital Health Health IT Healthcare IT 84

Digital Health Global

APRIL 5, 2024

ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 Infectious Disease Diagnostics has become a key focus area, with multiple players entering the field. The research provides an in-depth look at the current and future market participants driving growth in this sector. Tasso scores $6.1M

BioTech 88

BioTech Digital Health Medicare Telehealth 88

Healthcare IT Today

AUGUST 1, 2023

Originally announced July 12th, 2023 A member of the Sequoia Project, Parker Health is dual headquartered in Washington, DC and Dallas, TX, with offices in Menlo Park, CA. To learn more, visit ourparker.com.

BioTech 52

BioTech FHIR Pharmaceuticals Interoperability 52

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. In the coming year, we will see more AI tools begin to be built into existing workflows, rather than acting as a standalone aid.

Health IT 81

Health IT Drug Development Pharmaceuticals BioTech 81

Digital Health Global

MARCH 4, 2024

This is the second cohort for the One Mind Accelerator since the program’s launch in 2023. From digital health to biotech, from Pre-Seed to Series B, and from first-time founders to serial entrepreneurs, this cohort is indeed eclectic.

Mental health 88

Mental health BioTech Digital Health Psychiatry 88

Digital Health Global

MAY 24, 2023

In April 2023 the IPTC reported that 78% of compassionate-use bacteriophage treatments for antibiotic-resistant infections given since 2018 to patients at the Hadassah Medical Center and other hospitals in Israel have resulted in favorable outcomes.

BioTech 88

BioTech Digital Health 88

Digital Health Global

FEBRUARY 7, 2023

3CC prioritizes early-stage investments in “Third Culture entrepreneurs” whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech. Ciba Health was recently named among NY Digital Health 100 winners for 2023.

Chronic pain management 88

Chronic pain management BioTech Pain management Healthcare Innovation 88

Healthcare IT Today

MARCH 23, 2023

To help navigate these efforts, the company has added Dr. Sharon Shacham, a serial biotech entrepreneur and Founder of Karyopharm Therapeutics, to Protai’s Board of Directors. Originally announced March 15th, 2023 In addition, Protai is supported by leading oncology experts, including Prof.

Drug Development 70

Drug Development BioTech Health IT Healthcare IT 70

Digital Health Today

NOVEMBER 28, 2023

This unparalleled gathering of healthcare and biotech leaders showcases the enduring power of collaboration and innovation, shaping the future of healthcare. Despite the significant costs, poor weather, and the time spent in transit, the JPM Conference remains an undeniable force for the healthcare and life sciences industry.

Life Science 52

Life Science BioTech Pharmaceuticals Healthcare Innovation 52

Health Populi

MAY 8, 2019

In a call with analysts this week in which I participated, Murray Aitken discussed the report which looks back at 2018 and forward to 2023 with scenarios about what the U.S. prescription drug market might look like five years from now. A cost of $125 or more yields abandonment of at least 50%.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149